thymidine uptake by resting BALB/c or (C57BL/6 x DBA/2)F] (BDF~) B cells (5) cultured with either a soluble monoclonal rat anti-mouse IgM antibody (Bet2) (15) or with Sepharose coupled to affinity-purified goat anti-mouse Ig (S-GAMIg) or goat anti-mouse 6 (S-GAM-6) (16) . BSF-1 preparations were added at the initiation of culture and ['~H]-thymidine (1 pCi/well) was added for the last 16 h of the 72 h culture period. BSF-1 activity was reported either as a stimulation index [3H]thymidine uptake in the presence of BSF-1/['~H]thymidine uptake in its absence) or in units (U), where 1 U represents the amount of BSF-I required for half-maximal stimulation induced by a standard preparation of the BSF-l-containing EL-4 SN.
(b) BCDF-~F activity was measured by culturing T cell-depleted BDFI spleen cells in 96-well Costar plates for 16 h in medium containing 20 #g/ml of LPS (10) . Purified BSF-1 or unfractionated SN were added after 16 h and the cells were incubated for an additional 5 d. On the 6th d, the cell SN were harvested and assayed in a solid phase radioimmunoassay (RIA) for the presence of secreted IgG1 and IgG3 (10) .
(c) BCDF,p activity was determined using the in vitro-adapted clone of BCL~ cells (3B3) (17) . Factors to be tested for BCDF-p activity were added at the initiation of the 6-d culture and the cells were incubated at 37°C in an atmosphere of 5% CO2. The cell SN were harvested and assayed by a solid phase RIA for the presence of secreted IgM (17) .
Results

BCDF-"F Activity of Purified BSF-1. Preparations of HPLC-purified BSF-1 and
affinity-purified BSF-1 were tested for their activity in the BSF-1, BCDF-~,, and BCDF-u assays. 2-10 U/ml of BSF-1 in conjunction with S-GAMIg or S-GAM-6 caused striking increases in [~H]thymidine uptake and induction of lgG1 secretion and parallel inhibition of IgG3 secretion in LPS-stimulated cells (Fig. 1) . The increases in IgG1 secretion and decreases in IgG3 secretion caused by BSF- 1 preparation were similar in magnitude to those obtained using the SN of the concanavalin A-pulsed, alloreactive T cell clone PK 7.1 (18) , the standard source of BCDF-'y (see Fig. 1 legend) . It should be noted, however, that the majority of the cells producing IgG1 and IgG3 are different (19) . Neither HPLC-purified BSF-1 nor affinity-purified BSF-1 bad any activity in the BCDF-/~ assay ( Fig. 1) , although the PK 7:1 SN was positive (see legend, Fig. 1 ). The effluent from the anti-BSF-1 affinity column was devoid of both BSF-1 and BCDF-"r activity but contained IL-2 and BCDF-# activity (data not shown). HPLC-purified BSF-1 was further purified by SDS-PAGE. Extracts of eight individual bands, migrating with apparent Mr of slightly more than 20,000 to 14,000, were tested for BSF-1 and BCDF-3, activity. Fig. 2 illustrates a strong quantitative correlation between BSF-1 and BCDF-'y activities, with the three bands of Mr 20,000 having substantial activity in both assays. No BSF-1 or BCDF-3, activity was found in the lower molecular weight bands.
Depletion of BSF-1 and BCDF-~, from T Cell Supernatants with a Monoclonal Anti-BSF-1 Antibody Coupled to Sepharose.
We next determined whether BSF-1 was the principal molecular species with BCDF-'y activity in the standard PK 7.1 SN (10). Since the IgGl-inducing factor produced by both PK 7.1 SN (10) and a T cell hybridoma (11) has been reported to have an Mr of 20,000 and, in the case of the T cell hybridoma (11), pIs similar to those of BSF-1 (12), we subjected SN from induced PK 7.1 cells to affinity chromatograpby using Sepharose conjugated to l 1B11. As shown in Fig. 3 , the column removed BSF-I and BCDF-~, but not BCDF-~ activity from PK 7. I SN. FIC-URE 2. BCDF-3, (l~) and BSF-1 (Q) activity of HPLC-purified BSF-1 fractionated on 20% SDS-PAGE. The gel was stained with Coomassie Blue, and individual bands were cut from the geJ and eluted in phosphate-buffered saline containing 0.1% SDS. BCDF-2¢ activity was measured using 2 ~l of extract. BSF-1 activity was measured using dilutions of extract from l:l 0 to 1:100 and is reported in units. The background response in the BCDF-3, assay was 3 _+ 0.4 ng/ml IgG. The experiment was repeated three times with similar results. pl SN/CULTURE FIGURE 3. The monoclonal anti-BSF-1 antibody (11B11) coupled to Sepharose depleted BSF-1 and BCDF-~, activity from PK 7.1 SN, but had no effect on BCDF-~ activity. Briefly, 5.0 ml of PK 7.1 SN were passed over 1.0 ml of Sepharose anti-BSF-1. The material not adhering to the columns (0) was assayed for BCDF-% BCDF-u, and BSF-1 activities. In each case, the assay was compared with the PK 7.1 SN before passage over the affinity column (©). In the absence of PK 7.1 SN, the amount of IgM secreted in the BCDF-tt assay was 30 "4-6 ng/ml and the amount of IgG1 secreted in the BCDF-~, assay was 255 +_. 18 ng/ml. prepared in nude mice, was tested for its ability to inhibit the activity of PK 7.1 SN in the BSF-1 and BCDF-3' assays. Both functions were fully inhibited by 10 #1 of a 1:1000 dilution of 11B11 ascitic fluid but not by a control ascitic~fluid containing a monoclonal anti-DNP antibody (50C1) (Fig. 4) . In contrast, the BCDF-# activity of PK 7.1 SN was not inhibited by 11B11 ascitic fluid.
Ability of Monoclonal
Discussion
The observations that the induction of IgGl secretion and inhibition of IgG3 secretion in LPS-stimulated B cells are functions of BSF-1 indicate a need to reexamine the mechanism of action of this lymphokine. Recent evidence (7, 8) has established that BSF-1 is a potent activation factor for resting B cells. In contrast, BSF-1 has little or no capacity to sustain proliferation of B cell blasts after treatment with anti-Ig (9) or anti-~ plus BSF-1 (20) .
The present findings, taken together with results of past studies, suggest that BSF-1 is a pleiotropic activation factor. Thus, it appears to have differential effects on resting B cells and on a subset of LPS-stimulated B cells. These divergent effects could result from different biochemical events initiated by the lymphokine. Alternatively, a similar biochemical event induced by BSF-1 could lead to distinct pathways of gene activation or suppression that depend on the state of differentiation of the target cell. To explore these alternatives, it will be important to determine whether BSF-1 regulates the expression of other classes of immunoglobulin in activated B cells and whether the biochemical events induced by BSF-1 in resting and activated B cells are the same or different.
Summary
By three criteria, we have demonstrated that B cell stimulatory factor (BSF-1) and B cell differentiation factor (BCDF-~') are the same lymphokine. Highly purified preparations of high performance liquid chromatography-purified or affinity-purified BSF-1 had BCDF-'~ activity but not BCDF-u activity. A monoclonal anti-BSF-1 antibody coupled to Sepharose depleted both BSF-1 and BCDF-3/activity but not BCDF-# activity from two different T cell supernatants. Soluble monoclonal anti-BSF-1 blocked the BSF-1 and BCDF-3, but not the BCDF-~ responses. These results suggest that BSF-1 acts on both resting and activated B cells to induce different effects.
